Skip to main content
SupplementScience

Palmitoylethanolamide (PEA) — Frequently Asked Questions

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Frequently Asked Questions

Is PEA a cannabinoid?

No. PEA is classified as an endocannabinoid-like lipid (or ALIAmide). It does not bind CB1 or CB2 cannabinoid receptors and has no psychoactive effects. It enhances the endocannabinoid system indirectly by inhibiting FAAH enzyme, which breaks down anandamide. PEA is legal everywhere and will not cause a positive drug test.

Why is micronized PEA better than regular PEA?

Standard PEA is a lipophilic crystal that dissolves poorly in the GI tract. Micronization reduces particle size to 2-10 micrometers, dramatically increasing surface area and dissolution rate. Clinical trials showing significant pain benefits almost exclusively use micronized or ultra-micronized PEA. Standard PEA powder has very low bioavailability.

How long does PEA take to work for pain?

Some patients notice improvement within 2-3 weeks, but optimal effects typically develop over 4-8 weeks of daily use. A common protocol is 600mg twice daily for 3-4 weeks, then reducing to 600mg once daily for maintenance. PEA builds up gradually in tissues rather than providing immediate pain relief.

Full Palmitoylethanolamide (PEA) Guide

References

  1. (). Palmitoylethanolamide, a special food for medical purposes, in the treatment of chronic pain: a pooled data meta-analysis. Pain Physician.
  2. (). Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series. Journal of Pain Research. DOI
  3. (). The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. British Journal of Pharmacology. DOI